🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Inherited Hematological Diseases

A Clinical Study to Assess Sutacimig in Participants With Congenital Factor VII Deficiency NCT07347249Phase 21 site📍 London Hemab ApS · Tests: Sutacimig, Sutacimig Sickle-cell Disease Registry of the GPOH NCT03327428n/a1 site📍 Heidelberg University Hospital Heidelberg An Observational Study to Learn More About How Well Damoctocog Alfa Pegol Works in Previously Treated Children With Hemophilia A NCT07088458n/a12 sites📍 Loma Linda📍 New Brunswick📍 Many Locations Bayer · Tests: Damoctocog alfa pegol (Jivi, Bay94-9027) Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs NCT06111638Phase 2, Phase 310 sites📍 Beijing📍 Guangzhou📍 Guiyang Shanghai Xinzhi BioMed Co., Ltd. · Tests: Single dose intravenous injection of BBM-H803 BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases NCT06794008Phase 21 site📍 Beijing Peking University People's Hospital · Tests: BCMA-CD19 CAR-T therapy Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa NCT05285917Phase 31 site📍 Luanda Brown University · Tests: Hydroxyurea Endothelial Colony-Forming Cells in Patients With VWD, AVWS and Healthy Subjects NCT07358013n/a1 site📍 Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Tests: Blood sample collection for VWF measurements in plasma, Blood sample collection for ECFC isolation and characterization… Safe Threshold to Discontinue Phototherapy in Hemolytic Disease of Newborn NCT04218318NA1 site📍 Madinah Ministry of Health, Saudi Arabia · Tests: phototherapy Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants NCT03937817n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… A Study to Evaluate the Safety and Efficacy of ZS801 in Adult Hemophilia B Patients NCT05641610Phase 1, Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: ZS801 Manual Therapy in Hemophilic Arthropathy of the Ankle NCT06816056NA1 site📍 Murcia Investigación en Hemofilia y Fisioterapia · Tests: Manual Therapy, Placebo A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease NCT06998524Phase 329 sites📍 Sacramento📍 Gainesville📍 Lexington Hoffmann-La Roche · Tests: Emicizumab, von Willebrand Factor (VWF) Concentrates, Factor VIII (FVIII) Concentrates, von Willebrand Factor (VWF) and… Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency NCT06090669Phase 11 site📍 Bethesda National Cancer Institute (NCI) · Tests: TruSight Oncology, imatinib Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease NCT06385886n/a9 sites📍 Birmingham📍 Phoenix📍 Oakland RTI International · Tests: Linkage Coordinator Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study NCT05916469n/a9 sites📍 Palo Alto📍 Aurora📍 Atlanta Oregon Health and Science University · Tests: Levonorgestrel Intrauterine System, Norethindrone Acetate Adiposity and Iron Requirements in Pregnancy NCT06425796NA3 sites📍 Coleraine📍 Coleraine📍 Coleraine University of Ulster · Tests: Adiposity and Iron Requirements in Pregnancy (ADIPREG) A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease NCT06612268Phase 3175 sites📍 Birmingham📍 Mobile📍 Phoenix Novo Nordisk A/S · Tests: Etavopivat, Placebo World Bleeding Disorders Registry NCT03327779n/a1 site📍 Montreal World Federation of Hemophilia The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease NCT06975865Phase 363 sites📍 Birmingham📍 Phoenix📍 Clovis Sanofi · Tests: Rilzabrutinib, Placebo Blood Sampling for Research Related to Sickle Cell Disease NCT00542230n/a1 site📍 Bethesda National Institute of Diabetes and Digestive and Kidney Dis… Vasculitis Pregnancy Registry NCT02593565n/a1 site📍 Tampa University of Pennsylvania · Tests: Online questionnaires SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors NCT04647227Phase 421 sites📍 Phoenix📍 Little Rock📍 Los Angeles American Thrombosis and Hemostasis Network · Tests: coagulation factor VIIa [recombinant]-jncw A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) NCT01351545n/a142 sites📍 Birmingham📍 Gilbert📍 Phoenix Center for International Blood and Marrow Transplant Resear… · Tests: A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) Quality of Life in Pediatric Participants With HHT NCT07474428n/a1 site📍 Cincinnati Ashley Nelson Bone Loss, Physical Function and Frailty in Older Women With Sickle Cell Trait Sickle Cell Trait NCT07083531n/a1 site📍 Farmington UConn Health · Tests: Healthy volunteers without SCT, Healthy volunteers with SCT Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease NCT07566494Phase 11 site📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) · Tests: VAS-101 A Long-term Follow-up Study in Patients Who Received BEAM-101 NCT07373639n/a17 sites📍 Birmingham📍 Phoenix📍 Jacksonville Beam Therapeutics Inc. · Tests: Long-Term Follow-up Study of patients who received BEAM-101 Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease NCT06941389n/a37 sites📍 Birmingham📍 Birmingham📍 Wilmington University of Rochester Natural History of Sickle Cell Disease NCT00081523n/a3 sites📍 Washington D.C.📍 Bethesda📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy